Medication
24hrDoc
September 24, 2026
2.8/10
Medications
Cerebral's commercial site lists weight management and nutrition among its service areas, but does not currently publish a dedicated weight-program description, medication list or…
September 24, 2026
4.9/10
Medication
alli 60 mg orlistat weight-loss aid
alli is an over-the-counter orlistat 60 mg weight-loss aid for adults, used with a reduced-calorie, low-fat diet. MyAlli provides the official product information and…
September 24, 2026
7.9/10
Medication
Omada Prevention & Weight Health
Omada Health is a virtual, benefit-based health program. Its Prevention & Weight Health service combines a health coach, weekly learning, tracking tools and, for…
September 24, 2026
6.9/10
Medication
Parsley Health Reproductive Care
Parsley Health provides functional and reproductive-health care, including clinician visits, diagnostic testing and nutrition coaching. Its fertility-related support sits within a broader membership and…
September 24, 2026
6.2/10
Medication
Reverse Health Wellness App
Reverse Health is a subscription wellness app for women over 40, with meal plans, recipes, exercise videos and progress tools. Its terms say the…
September 24, 2026
6.8/10
Medication
Winona Menopause Care
Winona is a menopause-focused telehealth service offering prescription hormone therapy and non-hormonal options. It is not a weight-loss clinic and does not prescribe GLP-1…
September 24, 2026
5.9/10
Medication
Foundayo (orforglipron) tablets
Once-daily oral GLP-1 pill from Eli Lilly, FDA-approved April 1, 2026 for weight management in adults. Launch self-pay price from $149/month for the lowest…
September 20, 2026
Medication
Mounjaro (tirzepatide)
Once-weekly tirzepatide injection from Eli Lilly, FDA-approved for type 2 diabetes. Not approved for weight management. Official self-pay price not publicly verified (Sept 20,…
September 20, 2026
Medication
Zepbound (tirzepatide)
Once-weekly tirzepatide injection from Eli Lilly, FDA-approved for chronic weight management and obstructive sleep apnea in adults with obesity. Self-pay $299 to $449/month via…
$299/mo
Medication
Ozempic (semaglutide) injection
Once-weekly semaglutide injection from Novo Nordisk, FDA-approved for type 2 diabetes and related heart and kidney risk reduction. Not approved for weight management. Self-pay…
$349/mo
Medication
Wegovy (semaglutide) tablets
Once-daily oral semaglutide tablet from Novo Nordisk, FDA-approved December 2025 for weight management and cardiovascular risk reduction in adults. Self-pay $149 to $299/month by…
$149/mo